|
| Press Releases |
|
 |
|
| Monday, May 9, 2022 |
|
|
骏高公布二零二二年首季业绩 业务稳步发展 令收益增长 |
于香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供应商骏高控股有限公司（「骏高」或「集团」；股份代号：8035），今天公布其2022年3月31日止三个月（「回顾期」）的未经审核2022年首季业绩。
more info >> |
|
|
駿高公布二零二二年首季業績 業務穩步發展 令收益增長 |
| 於香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商駿高控股有限公司（「駿高」或「集團」；股份代號：8035），今天公布其2022年3月31日止三個月（「回顧期」）的未經審核2022年首季業績。 more info >> |
|
|
Janco Announces 2022 First Quarter Results, Business Steadily Develops as Revenue Grows |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a comprehensive freight forwarding and logistics services provider founded and based in Hong Kong with a strategic focus on Asia, has today announced its 2022 unaudited results for the three months ended 31 March 2022 ("Period under Review"). more info >> |
|
| Monday, April 25, 2022 |
|
|
骏高经审计之二零二一年全年业绩：股东应占溢利增加54.5%至17.3百万港元 |
| 于香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供货商骏高控股有限公司（「骏高」或「集团」；股份代号：8035）公布截至2021年12月31日止年度经审计之全年业绩（「回顾年内」）。 more info >> |
|
|
駿高經審計之二零二一年全年業績：股東應佔溢利增加54.5%至17.3百萬港元 |
| 於香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商駿高控股有限公司（「駿高」或「集團」；股份代號：8035）公布截至2021年12月31日止年度經審計之全年業績（「回顧年內」）。 more info >> |
|
|
Janco 2021 Audited Annual Results: Profit Attributable to Shareholders Surges by 54.5% to HK$17.3 million |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a one-stop freight forwarding and logistics service provider founded and based in Hong Kong with a strategic focus on Asia, announced its 2021 audited annual results for the year ended 31 December 2021 ("Year under Review"). more info >> |
|
| Sunday, March 27, 2022 |
|
|
骏高控股公布二零二一年全年业绩 |
| 骏高控股有限公司（「骏高」或「集团」；股份代号：8035） 是在香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供货商，公布截至2021年12月31日止年度之二零二一年未经审核*之初步全年业绩。 more info >> |
|
|
駿高控股公布二零二一年全年業績 |
| 駿高控股有限公司（「駿高」或「集團」；股份代號：8035） 是在香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商，公布截至2021年12月31日止年度之二零二一年未經審核*之初步全年業績。 more info >> |
|
|
Janco Holdings Announces 2021 Annual Results |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a well-established freight forwarding and logistics one-stop service provider founded and based in Hong Kong with a strategic focus on Asia, announced its 2021 unaudited* preliminary annual results for the year ended 31 December 2021. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
